This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

DexCom-Abbott patent validity and infringement claims to be heard jointly at UPC

( November 21, 2024, 15:34 GMT | Official Statement) -- MLex Summary: The Düsseldorf Local Division of the Unified Patent Court decided to jointly hear DexCom’s infringement claims and Abbott’s counterclaim for revocation, following the consent of the parties. The case concerns European patent 4,026,488, which relates to transcutaneous analyte sensor systems. This decision aims to ensure procedural efficiency by addressing both infringement and validity issues together before the same panel, the court said.The document is attached. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections